Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yallaferon in HPV-16/18 Infection
NCT02801383Phase 3Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa-2b in human papillomavirus infection, sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
interferon alfa-2b
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT02801383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801383.